| ASSET | YEAR | % RETURN |
|---|---|---|
GeneDx (WGS) | 2024 | 2,688.89% |
SoundHound AI (SOUN) | 2024 | 785.21% |
Rigetti Computing (RGTI) | 2024 | 647% |
D-Wave Quantum (QBTS) | 2024 | 623.86% |
Janux Therapeutics (JANX) | 2024 | 431.37% |
ADMA Biologics (ADMA) | 2024 | 297.78% |
Ast Spacemobile (ASTS) | 2024 | 292.49% |
Nextnav Acquisition (NN) | 2024 | 279.19% |
Banco Macro SA B ADR (BMA) | 2024 | 278.45% |
BBVA Banco Frances SA ADR (BBAR) | 2024 | 271.59% |
Avidity Biosciences (RNA) | 2024 | 244.24% |
Lumen Technologies (LUMN) | 2024 | 238.55% |
Longboard Pharmaceuticals (LBPH) | 2024 | 224.57% |
PureCycle Technologies (PCTTW) | 2024 | 214.04% |
Sweetgreen (SG) | 2024 | 213.45% |
Brinker International (EAT) | 2024 | 206.27% |
IONQ (IONQ) | 2024 | 205.75% |
Hims Hers Health (HIMS) | 2024 | 199.55% |
Rush Street Interactive (RSI) | 2024 | 197.96% |
United States Lime & Minerals (USLM) | 2024 | 195.77% |
Semtech (SMTC) | 2024 | 193.54% |
Edgewise Therapeutics (EWTX) | 2024 | 181.79% |
Powell Industries (POWL) | 2024 | 181.29% |
Vera Therapeutics (VERA) | 2024 | 176.64% |
IES (IESC) | 2024 | 168.91% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
